Chemoembolization, Radioembolization, and Percutaneous Ablation: New Opportunities for Treating Ovarian Cancer Liver Metastasis
Current Treatment Options in Oncology · 2024
DOI: 10.1007/s11864-024-01266-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Treatment Options in Oncology, 2024. Verfasst von Giuseppe Cucinella und 11 weiteren Autor:innen. Beteiligte Einrichtung: Gynecology Oncology Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy. giuseppecucinella@outlook.com. Hauptthemen laut MEDLINE: Liver Neoplasms, Ovarian Neoplasms, Chemoembolization, Therapeutic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
OPINION STATEMENT: Parenchymal liver metastases from ovarian cancer, occurring in 2-12.5% of cases, significantly worsen prognosis. While surgery and systemic treatments remain primary options, unresectable or chemotherapy-resistant multiple liver metastases pose a significant challenge. Recent advances in liver-directed therapies, including radiofrequency ablation, microwave ablation, cryoablation, transarterial chemoembolization (TACE), and radioembolization, offer potential treatment alternatives. However, the efficacy of these techniques is limited by factors such as tumor size, number, and location. The ideal candidate for tumor ablation is a patient with paucifocal disease, a single tumor up to 5 cm or up to 3 tumors smaller than 3 cm and tumors 1 cm away from major bile ducts and high-flow vessels. Transarterial chemoembolization could be performed in patients with less than 70% tumor load. Differently, radioembolization is available with less limitation on the sites or number of liver cancers. Radioembolization techniques are also able to downsize liver metastases. However, there are limited data regarding the outcomes of loco-regional therapy in patients with hepatic metastases from ovarian cancer. Advancing liver-directed therapies through interventional oncology, combined with robust data on the oncological efficacy of these local treatments, will validate their potential as effective locoregional therapies for liver metastases. This could offer a promising treatment option for patients with ovarian cancer and unresectable hepatic metastases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gynecology Oncology Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy. giuseppecucinella@outlook.com.
- Gynecology Oncology Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy.
- Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127, Palermo, Italy.
- Ospedale San Leonardo, Castellammare di Stabia, ASL NA3 SUD, Naples, Italy.
- Unit of Gynecologic Oncology, ARNAS "Civico-Di Cristina-Benfratelli", University of Palermo, 90127, Palermo, Italy.
- Clinic of Obstetrics and Gynecology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
Zitieren
APA
Cucinella, G., Di Donna, M. C., De Maria, F., Etrusco, A., Zaccaria, G., Buono, N., Abbate, A., Restaino, S., Scaffa, C., Vizzielli, G., Laganà, A. S., & Chiantera, V. (2024). Chemoembolization, Radioembolization, and Percutaneous Ablation: New Opportunities for Treating Ovarian Cancer Liver Metastasis. Current Treatment Options in Oncology. https://doi.org/10.1007/s11864-024-01266-5
Vancouver
Cucinella G, Di Donna MC, De Maria F, Etrusco A, Zaccaria G, Buono N, et al. Chemoembolization, Radioembolization, and Percutaneous Ablation: New Opportunities for Treating Ovarian Cancer Liver Metastasis. Current Treatment Options in Oncology. 2024. doi:10.1007/s11864-024-01266-5
BibTeX
@article{Cucinella2024,
author = {Cucinella, Giuseppe and Di Donna, Mariano Catello and De Maria, Francesca and Etrusco, Andrea and Zaccaria, Giulia and Buono, Natalina and Abbate, Antonino and Restaino, Stefano and Scaffa, Cono and Vizzielli, Giuseppe and Laganà, Antonio Simone and Chiantera, Vito},
title = {Chemoembolization, Radioembolization, and Percutaneous Ablation: New Opportunities for Treating Ovarian Cancer Liver Metastasis},
journal = {Current Treatment Options in Oncology},
year = {2024},
doi = {10.1007/s11864-024-01266-5}
}
EUVIMED